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Abstract 
Unloading during spaceflight alters the microstructure of bone resulting in a significant 
reduction in bone health. Hind Limb Unloading (HLU) in mice is used to study the 
musculoskeletal changes caused by spaceflight. This study investigates the effects of HLU on 
bone stiffness and structural efficiency using Finite Element Analysis (FEA) on the proximal 
tibia of mice from a HLU study mimicking space shuttle mission STS-135 (13-days of 
spaceflight). Structural bone health was compared between HLU and spaceflight in terms of 
bone stiffness and structural efficiency as well as their response to Sclerostin antibody (Scl-Ab). 
HLU and spaceflight had the same effect on BV (-17%); however, spaceflight caused a greater 
decrease in stiffness (-34%) compared to HLU (-22%). Scl-Ab prevented the loss of BV and 
stiffness in the HLU and spaceflight groups. The spaceflight model showed a greater decrease in 
structural efficiency (-22%) between the flight vehicle and ground control groups compared to 
HLU (-5%).The difference in structural efficiency from unloading can be attributed to the 
incomplete unloading in HLU. Future studies should investigate the mechanisms resulting in the 
changes in structural efficiency to further characterize differences in the HLU model and 
microgravity in spaceflight.  
 
Introduction 
Spaceflight and bedrest cause a -.35% reduction in total Bone Mineral Density (BMD) 
per month, reducing the bone health of astronauts and patients on bedrest significantly (LeBlanc 
et al., 1996). Investigating the structural changes caused by microgravity conditions can lead to 
improved therapies for an expansive population affected by bone disease and bed rest. There are 
over 70 million people worldwide at risk for fractures which have been shown to significantly 
increase morbidity (Boyle, Simonet, & Lacey, 2003). Mortality rate increases from 3% to 14.8% 
after operation for proximal femoral fractures for people over 50 years old (Sexson & Lehner, 
1987) . The clinical significance is most important for patients with osteoporosis, especially for 
women who are at higher risk due to the 7.2% incidence of new vertebral fractures within 3 years 
post menopause (Bone et al., 2013).  
Sending mice to space allows rapid testing of bone loss countermeasures, because of the 
rapid turnover rate of bone in microgravity environments. Ground models approximating the 
effects of unloading seen in mice sent to space allow less expensive means of testing drugs and 
studying bone remodeling (Morey-Holton & Globus, 2002). Furthermore, spaceflight 
experiments provide critical information about the health of astronauts (Morey-Holton & Globus, 
2002). The goal of this study was to investigate the structural changes of tibia bones due to Hind 
Limb Unloading (HLU) in mice, including differences in trabecular and cortical compartments. 
To accomplish the objective of this study stiffness normalized by bone volume was 
determined with Finite Element (FE) modeling from micro Computed Tomography (microCT) 
scans. The contribution of cortical and trabecular components to bone volume, effective 
stiffness, and structural efficiency of the whole bone was investigated to provide more detailed 
information. Additionally, the bone loss countermeasure, Sclerostin Antibody (Scl-Ab), was 
administered to sub groups of the HLU and spaceflight study groups to analyze differences in 
effectiveness of the drug in the 2 unloading conditions. 
Background 
Bone is comprised of mineralized and nonmineralized (osteoid) tissue. In long bones 
such as the femur and tibia, cortical bone is the outer region that supports most of the uniaxial 
load applied to the body. The other major component is trabecular bone, the inner region of long 
bones consisting of trabeculae struts of about 167𝜇m thick that support smaller loads but in many 
directions (Ding & Hvid, 2000). Bone marrow is located in the center along the length of long 
bones. Cortical bone is dense and organized in a haversian system which consists of concentric 
layers (lamellae) of bone tissue around a central haversian canal (osteon) where blood vessels are 
located. There are 3 bone cells that control bone remodeling: osteoblasts that form new bone, 
osteoclasts that remove bone, and osteocytes that function as mechanotransducers. Bone cells 
communicate by signaling molecules or direct contact through small canals called canaliculi. 
(Boskey & Robey, 2013) 
Bone remodeling occurs throughout life at a rate of 4 to 10% per year and is dependent 
on many environmental factors including diet, estrogen levels, and exercise (Franz‐Odendaal, 
Hall, & Witten, 2006). The balance of osteocytes and osteoblasts controls bone health. This 
balance is achieved through signaling molecules and cell-cell interactions. For example, the 
formation of bone resorptive cells, osteoclasts, require cytokines especially Receptor Activator 
of Nuclear Factor Kappa-B Ligand (RANKL) which prime precursor cells; however other 
cytokines such as osteoprotegerin (OPG) inhibit RANKL. When activated, osteoclasts isolate 
their acidic environment to the surface of bone which exposes the organic matrix, mainly type I 
collagen that is degraded by the lysosomal enzyme cathepsin K. Integrins are essential for 
attaching the osteoclasts to the bone matrix. Also important in the bone resorption process are the 
ruffled zone which is formed when osteoclasts attach to the bone surface, and the sealing zone 
which restrains the acidic environment to the surface of the bone matrix. Discoveries in bone 
resorption have mainly stemmed from biochemical and molecular experiments, and experiments 
with mice lacking specific genes. (Ross, 2013) 
Cytokines are also important for osteoblast differentiation from mesenchymal stem cells. 
Hedgehogs, Bone Morphogenetic Proteins, Transforming Growth Factors, Parathyroid 
Hormones, and Wingless-related Integration sites (Wnt) are all involved in initiating the signal 
transduction cascades necessary for osteoblast differentiation (de Gorter & ten Dijke, 2013). 
When the bone forming phase is complete, some osteoblasts become lining cells (deactivated) 
and some undergo apoptosis (Franz‐Odendaal et al., 2006). Other osteoblasts slow down 
production of bone matrix and become buried by matrix from other osteoblasts, thereby 
becoming osteocytes (Franz‐Odendaal et al., 2006). Osteocytes are the most abundant bone cell, 
making up 90-95% of all bone cells (Franz‐Odendaal et al., 2006). They are distributed 
throughout mineralized matrix, and have long dendritic processes that extend through the 
canaliculi from the bone marrow to the bone surface (Bonewald, 2013).  
Sclerostin Antibody 
Sclerostin is a protein encoded by the SOST gene that regulates osteoblast activity by 
interfering with its development through the Wnt pathway and triggering apoptosis. In diseases 
such as Sclerosteosis and Van Buchem, the SOST gene has mutations in the coding region or a 
regulatory region downstream which prevents sclerostin production or down regulates it 
respectively. These conditions result in abnormally high levels of bone growth. Sclerostin 
Antibody (Scl-Ab) works in a similar manner, preventing the function of sclerostin so that more 
bone growth occurs. (Yavropoulou, Xygonakis, Lolou, Karadimou, & Yovos, 2014) 
 
Mouse Model 
 C57Bl/6 mice have been extensively used to study bone loss. Their skeletal growth is 
similar to human bone growth.  Several studies have shown that peak volumetric Bone Mineral 
Density (vBMD) is achieved between 3-6 months of age; however, ash fraction, representing the 
tissue level density, does not change significantly from 4 to 24 weeks (Somerville, Aspden, 
Armour, Armour, & Reid, 2004). This indicates that material density of bone remains constant, 
while mineral content increases (Somerville et al., 2004). These results were also supported by 
Silva et al., whose work determined that peak bone strength of C57Bl/6 female mice is not 
reached before 20 weeks of age, and that densitometric properties remained constant from 4-24 
weeks (Brodt, Ellis, & Silva, 1999). Bone loss with aging in C57Bl/6 mice has also been 
documented to be similar to human bone loss (Halloran et al., 2002). Humans reach peak BMD 
between 10-19 years of age; however Bone Mineral Content (BMC) continues to increase to 30-
35 years of age (Halloran et al., 2002). This trend in bone growth occurs because radial growth 
of bone and increased mineralization occurs after peak BMD is reached (Halloran et al., 2002). 
After bone growth, BMD and BMC decrease with age (Halloran et al., 2002). The male 
C57Bl/6J mice used in this study reached peak bone mass at 12-13 months, about half of their 
life span, similar to humans (Halloran et al., 2002). 
The mouse skeletal system is similar to human bone; however there are some important 
differences. C57Bl/6 mice lack the cortical organization present in the haversian system of 
human cortical bone (Jilka, 2013). Thus, remodeling of cortical bone in mice and humans occurs 
in different manners. Bone turnover in mice is about 0.7% per day measured in the distal femur 
and each remodeling episode takes 2 weeks to complete (Jilka, 2013). In contrast, human bone at 
the iliac crest turns over at about 0.1% per day and each event takes about 6-9 months to 
complete (Jilka, 2013). The quick turnover rate of mouse bone makes them useful for modeling 
bone loss in humans. Mouse trabeculae are between 20-50𝜇m thick, whereas human trabeculae 
are about 167𝜇m thick, which is important when considering imaging techniques to quantify 
changes in trabecular microstructure (Christiansen, 2013). 
 
Imaging 
 Dual-energy X-ray Absorptiometry (DXA) is a type of imaging used to assess bone 
health by quantifying BMD. However, BMD only moderately correlates with bone strength 
which is the best predictor of fracture risk. Improvements in imaging techniques have allowed 
for the analysis of microcracks in cortical bone and trabecular bone architecture, contributors to 
overall bone strength. With current improvements in imaging techniques, it is expected that 
knowledge of microarchitecture of bone can eventually be used in the clinical setting to assess 
bone strength. Peripheral Quantitative CT (pQCT) can be used to analyze trabecular architecture 
in large animals and cadaver bones; however, the resolution (70𝜇m) is too low for analysis of 
trabeculae in rodent models. Radiation dose from QCT scans prevent its use to analyze the hip in 
the clinical setting. Furthermore, partial volume averaging needs to be considered with low 
resolution imaging, especially if trabecular bone is being analyzed (167𝜇m thick trabeculae). 
MicroCT can obtain resolutions up to 5um, allowing analysis of rodent trabecular architecture. 
With the discovery of synchrotron radiation (resolution <1𝜇m), and forms of MicroCT scanners 
that can be used in vivo, clinical assessment of bone health should improve. (Christiansen, 2013)  
 
Spaceflight Model  
Lang et al. has investigated bone loss in astronauts from long duration spaceflight in 
terms of BMD and bone geometry using QCT and DXA, and Keyak et al. has investigated bone 
strength of astronauts using FE modeling. Lang et al. used volumetric QCT to analyze integral, 
cortical and trabecular vBMD in the hip and spine after long duration missions (4-6 months). 
They found a decrease in vBMD at 1.2-1.5%/month in the hip, with .4-.5%/month from cortical, 
and 2.2-2.7%/month from trabecular bone. (T. Lang et al., 2004) 
Lang, et al. also showed that reloading after spaceflight allows bone mass to recover but 
not vBMD. The loss of bone mass occurred by thinning of the cortex from the inner margin 
without compensatory periosteal apposition as seen in the aging process. They also found that 
new bone was less mineralized or more porous than what was previously lost, causing the slow 
recovery of vBMD. (T. F. Lang, Leblanc, Evans, & Lu, 2006) 
In a Flight Analog Study, human subjects participated in a head-down bed rest study 
showing similar BMD reduction to spaceflight in hip, pelvis, and heel (1%/month) (Spector, 
Smith, & Sibonga, 2009). These studies indicate the importance of developing countermeasures 
for bone loss from unloading conditions such as microgravity and bed rest.   
 
Hind Limb Unloading Model 
The HLU model established in 1979 by NASA Ames Research Center has been accepted 
and widely used to study the musculoskeletal changes caused by spaceflight (Morey-Holton & 
Globus, 2002). In this model mice experience: differential muscle atrophy, cephalad fluid shift, 
freedom to use forelimbs normally, ability to recover from unloading, and normal weight gain in 
young mice and normal weight loss in adult mice throughout the experiment (Morey-Holton & 
Globus, 2002). This study investigates bone changes in HLU, because research has shown 
similar declines in mineral density as seen in mice flown to space (Morey-Holton & Globus, 
2002). Although current evidence supports the model’s approximation of BMD loss in 
spaceflight, no studies have investigated the stiffness of the bone using Finite Element Analysis 
(FEA).  
Finite Element Analysis 
 FEA is used to simulate mechanical testing on bone to estimate bone strength without 
destroying the bone sample. With improved imaging and computational techniques, measures of 
bone strength can eventually be used for clinical diagnosis of osteoporosis, since BMD only 
moderately predicts bone strength. Keyak et al. showed that CT based nonlinear FE modeling of 
the proximal femoral strength estimated fracture risk better than areal BMD. (Keyak et al., 2013)  
In mechanical testing, failure load is the most important factor that determines fracture 
risk. It is a measure based not only on the amount of bone mass present, but also on the spatial 
distribution of trabeculae. Bone failure load determines the point at which the bone fails 
mechanically. In experimental compression tests, it is the load peak after which a decrease in 
load of at least 5% is observed on a force-displacement curve. (W Pistoia et al., 2004; Walter 
Pistoia et al., 2002) Pistoia et al. determined that the optimal parameters for 𝜇FE simulation 
prediction of failure load is obtained by setting a critical limit for which the bone tissue begins to 
fail. Literature has used 7000 microstrain as this critical limit based on strain energy density and 
young’s modulus of bone. The failure load in FE simulations is determined by the load at which 
more than 2% of the bone is strained beyond the tissue yield strain.(Walter Pistoia et al., 2002)  
Pistoia et al. used an isotropic and linear-elastic model with E=10GPa and v=0.3. 
However, bone is anisotropic, responding differently to loads applied in different directions. 
Additionally, cortical bone is stronger in compression than tension, making it a nonlinear 
material (Niebur, Feldstein, Yuen, Chen, & Keaveny, 2000). The assumptions of the model 
allow reasonable CPU time and memory allocation, although a nonlinear anisotropic model 
would predict failure load more accurately (Niebur et al., 2000).  
Keyak et al. used a nonlinear FEM with isotropic material properties to estimate proximal 
femoral strength. Ash density computed from the CT scanner was used to set a unique elastic 
modulus and material strength to each pixel using correlations previously determined for 
trabecular and cortical bone. After material failure, plastic flow was modeled with post failure 
properties based on ash density and previously reported correlations originally obtained for 
trabecular bone. They found the fall configuration for loading was better approximated by 
nonlinear models. (Keyak, 2001) 
Pistoia et al. used 𝜇FE based on images of 3D-pQCT images to show that bone mass 
measurements of the radius were poor predictors of failure load. The best predictor was BMC 
(R
2
=0.48). However, the 𝜇FE simulation estimated failure load with R2=0.75. Several structural 
parameters including a combination of Trabecular Number (Tb.N), Trabecular Threshold (Tb 
Th), Bone Volume Fracture (BT/TV), and Cortical Thickness (Cth) were also tested for ability to 
predict failure load (R
2
=0.57). (Walter Pistoia et al., 2002) 
Pistoia et al. used the same procedure to test a 1cm cross section of the radius. The results 
indicated that a 𝜇FE simulation of a small cross section of the radius is a better predictor for 
failure load compared to bone mass measurements and structural parameters; however, there is a 
reduction in coefficient of determination (R
2
=0.66) compared to simulations based on the whole 
radius. Measurements based on a small portion of bone will be important for moving from bench 
to bedside, since more imaging data will require more time and CPU power. (W Pistoia et al., 
2004) 
 Literature has used QCT, pQCT, and DXA with a range of resolutions to model bone and 
produce FE models. Pistoia used pQCT to model human radius bones and to estimate failure 
load. Keyak used QCT and nonlinear FEMs to estimate human femur and vertebrae failure loads. 
This study uses microCT scans of mouse tibia bones with resolution of 10𝜇m to obtain accurate 
representation of both cortical and trabecular bone microstructure. Since failure load assumes 
material properties of bone such as yield stress and point of fracture are known, this study uses 
stiffness as the main structural parameter. Stiffness is similar to failure load, except the material 
isn’t deformed past the tissue yield strain, which requires well known material properties of 
cortical and trabecular bone and a nonlinear model [kayak 2001]. Stiffness will be used to 
demonstrate the force (N) required to compress the structure by .5%.  
 
Materials and Methods 
 
Study Design 
The HLU experiment was designed and performed by Mary Bouxein at Harvard 
University. The protocol was made to mimic the STS-135 space shuttle spaceflight experiment 
where mice were exposed to microgravity conditions for 13-days. Mice on STS-135 were housed 
in the animal enclosure model developed by NASA to provide mice living space, food, water, 
ventilation, and lighting (Wigley, 2012). Table 1 provides a brief description of the two studies. 
A total of 60 female C57BI/6C mice 9 weeks of age at the start of the experiment were included 
in this study. The mice were acclimated to wire floors and fed with Nutrient-upgraded Rodent 
Food Bars according to NASA Ames protocol for 2 weeks prior to the experiment (Wigley, 
2012). Bone mineral density was measured 3 days before the start of the experiment using DXA 
under inhaled isoflurane anesthesia for about 8 minutes. One day prior to the start of the 
experiment, all mice received 2 subcutaneous injections to the back of either drug or vehicle and 
celcein bone label to detect developing bone. To begin the experiment HLU mice were put into 
tail suspension under inhaled isoflurane anesthesia for about 5 minutes, while control mice were 
exposed to a similar duration of anesthesia.  
29 mice were in HLU for 13 days in which 15 received Sclerostin Antibody (Scl-Ab) as a 
countermeasure for bone loss. The control group consisted of 29 mice in which 15 received Scl-
Ab countermeasure. These groups were not subjected to HLU but maintained all other aspects of 
the experimental group. To simulate reloading from spaceflight, the HLU mice were removed 
from their harness 3 hours prior to the beginning of dissection. All mice were completely 
dissected within 30 minutes of death. A 1.0mm thick cross section of the proximal tibia just 
inferior to the growth plate was dissected for microCT scanning and FE modeling. 
  
Table 1: HLU and Spaceflight Experiment Design 
Group Size 
 
Treatment Description 
HLU Ground Control n=15 Placebo Housed in Cages with No Tail 
Suspension 
n=15 100mg/kg Scl-Ab 
HLU n=15 Placebo Housed in Cages with Tail Suspension 
n=15 100mg/kg Scl-Ab 
Ground n=15 Placebo Housed in AEM at Kennedy Space 
Center n=15 100mg/kg Scl-Ab 
Spaceflight n=15 Placebo Housed in AEM on Space Shuttle 
Atlantis: STS-135 n=15 100mg/kg Scl-Ab 
 
FEA Modeling and Simulation Procedure 
The proximal tibia was scanned with a Scanco microCT scanner at 10𝜇m resolution. A 
threshold of 375mgHA/𝑐𝑚3(205 per mille) was chosen to include trabecular bone.These were 
used to generate subject specific FE models of each tibia bone. The microCT images were 
imported into ABAQUS CAE 6.9 for FE modeling and simulation. Figure 1 shows the models 
produced by the scans. Bone material properties were assumed to be homogenous (E=10 GPa, 
ν=0.3).  Bone stiffness was calculated as the resultant force (N) from the applied displacement 
(mm).  Structural efficiency, an indicator of how structurally efficient the bone is arranged, was 
calculated as the stiffness per bone volume.  
The superior and inferior surfaces of the tibia were initially fixed. A load was applied to 
displace the superior surface by .5%. The force at each node required to displace the surface 
.005mm was summed so that stiffness could be taken as the force per mm of displacement. The 
volume was calculated as the number of cuboidal elements in the mesh multiplied by the volume 
of each element (9.99× 10−7𝑚𝑚3). The structural efficiency of the bone was defined as the 
stiffness per total bone volume. These large FE problems, with on average 1 million elements, 
were solved using 3 CPUs and 38Gb of memory for each model, requiring approximately 40 
min. per model to complete the output database file. 
A separate mesh was generated using the proprietary Scanco software for cortical bone so 
that any differences in bone volume, stiffness, or structural efficiency between cortical and 
trabecular bone could be determined. Figure 2 shows a model before and after separation of 
cortical bone from whole bone. The same simulation was used for these meshes, and trabecular 
bone volume and stiffness was calculated as the difference between the whole and cortical bone 
values. Structural efficiency of trabecular bone was calculated from these results. 
  
Statistical Analysis 
Results are presented as mean ± SEM. Two way Analysis of Variance (ANOVA) 
analysis was used to establish the statistical significance of the data with p≤.05 being significant, 
signified in graphs with a * symbol. The Tukey Test was used to determine significant 
differences between groups only when the ANOVA resulted in p≤.05. Bone volume, stiffness, 
and structural efficiency were analyzed using this method. Qualitative comparisons were made 
between HLU and spaceflight groups.  
Results 
Figure 3 (a,b), shows the effect of HLU on bone volume and stiffness, as well as the 
effectiveness of Scl-Ab in the ground groups and HLU groups. HLU caused significant 
reductions in bone volume and stiffness, and Scl-Ab caused significant increases in bone volume 
 
Ground HLU
Figure 1: The figure above shows the finite element models produced from the microCT scans of 
mouse proximal tibia bones from a ground control group (Left) and a HLU group (Right). 
 
Control-Vehicle Cortical Only
Figure 2: The figure above shows a ground control model of whole bone (Left) and the 
subsequent model after extraction of the trabecular bone (Right). 
and stiffness with p<0.05. HLU resulted in a greater decrease in stiffness (-22%) compared to 
bone volume (-17%). Scl-Ab was more effective in the HLU condition compare to the ground 
controls with 48% and 37% increase in bone volume respectively. Scl-Ab caused a greater 
increase in stiffness (48%) compared to bone volume (37%) in the ground controls as well as the 
HLU groups (61% and 48% for stiffness and bone volume respectively). Overall, Scl-Ab 
recovered the loss in bone volume and stiffness from HLU. 
Shown in Figure 3 (c,d) are the counterparts of a and b for spaceflight. Spaceflight 
stiffness did not pass the normality test, and should be taken into consideration when analyzing 
results. Spaceflight also caused a significant -17% reduction in bone volume; however, the 
decrease in stiffness (-34%) was greater in spaceflight compared to HLU (-22%). The increase in 
bone volume in HLU from Scl-Ab (48%) was greater than the increase in spaceflight from Scl-
Ab (39%), but the ground controls for spaceflight showed a greater increase in bone volume 
from Scl-Ab (42%) compared to HLU (37%). The difference in the effects of Scl-Ab were 
greater in stiffness with the HLU experiment’s ground control experiencing a 48% increase in 
stiffness compared to a 60% in the ground control groups from the spaceflight study. However, 
Scl-Ab still caused a similar increase in stiffness for both HLU (61%) and spaceflight (62%) 
groups. 
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Figure 3 (a,b,c,d left to right, top to bottom): Shown above are the BV and stiffness results for 
whole bone. The percent change is noted along with the significance *(p<0.05). BV and stiffness 
results for HLU are shown in a and b respectively. BV and stiffness results for spaceflight are 
shown in c and d respectively. 
 Figure 4 (a,b) shows the cortical compartment bone volume and stiffness results from 
the HLU groups. HLU caused a significant decrease in cortical bone volume (-10%) and stiffness 
(-15%) with p<0.05. The increase in bone volume and stiffness from Scl-Ab was significant 
(p<0.05) in each of the ground groups, and recovered what was lost from HLU. Similar to whole 
bone, cortical bone stiffness was affected more by Scl-Ab compared to bone volume. 
 Shown in Figure 4 (c,d) are the counterparts to a and b for spaceflight. Spaceflight 
cortical efficiency failed normality and equal variance test, and should be taken into account 
when analyzing results. There was a slightly greater decrease in bone volume from spaceflight (-
14%) compared to HLU (-10%). A larger difference between HLU and spaceflight occurred for 
stiffness with a 15% decrease from HLU and a 32% decrease from spaceflight. Similar to whole 
bone, cortical bone had greater increases in bone volume and stiffness from Scl-Ab while in the 
HLU condition (35%, 52%) compared to the ground controls (24%, 34%). However, in the 
spaceflight groups, Scl-Ab was more or equally effective in the ground controls (33%, 48%) 
compared to the spaceflight groups (31%, 48%) for bone volume and stiffness respectively. In all 
cases, Scl-Ab recovered cortical bone volume and stiffness lost by unloading. 
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Figure 4 (a,b,c,d left to right and top to bottom): Shown above are the BV and stiffness results 
for cortical bone. The percent change is noted along with the significance *(p<0.05). BV and 
stiffness results for HLU are shown in a and b respectively. BV and stiffness results for 
spaceflight are shown in c and d respectively. 
 Figure 5 (a,b) shows the effect of HLU on trabecular bone volume and stiffness. The 
trabecular compartment failed to pass the equal variance test, because trabecular bone is sparser 
than cortical bone, and the study was limited to 15 mice per group; however this failure should 
be taken into account when analyzing resutls. HLU caused a significant decrease in bone volume 
(-58%) and stiffness (-56%). In contrast to whole and cortical bone, trabecular bone volume 
decreased slightly more than stiffness. Scl-Ab caused significant increases in bone volume and 
stiffness in the ground and HLU groups. Also similar to whole and cortical bone results, Scl-Ab 
had a greater effect on trabecular bone volume and stiffness in the HLU groups (194%, 156%) 
compared to ground controls (104%, 117%). 
 Shown in Figure 5 (c,d) are the counterparts to a,b for spaceflight. Unlike the effect in 
HLU, spaceflight caused a greater decrease in trabecular bone stiffness (-45%) compared to 
trabecular bone volume (-32%). Similar to all other results, Scl-Ab had a greater effect on bone 
volume and stiffness in the unloading condition (+95%, +131%) compared to the ground 
controls (+88%, +108%). In contrast to cortical bone results, trabecular bone volume decreased 
more from HLU (-58%) compared to spaceflight (-32%). Trabecular stiffness also decreased 
more from HLU (56%) compared to spaceflight (-45%). Scl-Ab caused greater increases in bone 
volume and stiffness in the HLU condition compared to spaceflight; however, the HLU ground 
controls also had greater increases in bone volume and stiffness from Scl-Ab compared to the 
spaceflight ground controls. 
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Figure 5 (a,b,c,d): Shown above are the BV and stiffness results for trabecular bone. The 
percent change is noted along with the significance *(p<0.05). BV and stiffness results for HLU 
are shown in a and b respectively. BV and stiffness results for spaceflight are shown in c and d 
respectively. 
 Figure 6 (a,b) shows the effect of HLU and spaceflight on structural efficiency of whole 
bone. Spaceflight caused a greater decrease (22%) in structural efficiency compared to HLU 
(5%). Scl-Ab caused a greater increase in structural efficiency in the spaceflight study compared 
to HLU in both the ground groups (13%,8%) and unloaded groups (16%,9%). Cortical bone 
structural efficiency followed a similar trend to whole bone results. Spaceflight also caused a 
similar effect on trabecular bone structural efficiency; however, HLU caused a different response 
in trabecular bone structural efficiency. There was not a significant difference between the HLU 
ground control group and the HLU ground group with Scl-Ab. Additionally, HLU caused a 8% 
increase in trabecular structural efficiency. Furthermore, the HLU group with Scl-Ab had a 16% 
reduction in structural efficiency compared to the HLU placebo group. 
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Figure 6 (a,b,c,d,e,f): Shown above are the efficiency results for whole (a,b), cortical (c,d), and 
trabecular bone (e,f) with HLU in the left column and spaceflight in the right column. The 
percent change is noted along with the significance *(p<0.05). BV results for HLU and 
spaceflight are shown in a and b respectively. Stiffness results for HLU and spaceflight are 
shown in c and d respectively. 
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Discussion 
The goal of this study was to investigate the effects of HLU on the structural properties of 
the tibia bone, and to compare these results to spaceflight bone loss in mice. The results 
demonstrated that structural properties of bone provide additional information to bone volume 
measurements. Spaceflight and HLU both reduced bone volume by 17%. However, spaceflight 
caused a greater decrease in stiffness (-34%) compared to HLU (-22%). Bone volume was 
expected to reduce by the same amount from both HLU and spaceflight, because studies have 
reported similar bone mineral density reductions in the two models, but the difference that 
occurred in stiffness has not been reported (Morey-Holton & Globus, 2002).  
 To investigate the differences between HLU and spaceflight between bone volume and 
stiffness further, the FE models were separated into cortical and trabecular compartments. 
Cortical bone reflected similar reductions in bone volume and stiffness (-14%, -32%) compared 
to whole bone (-17%, -34%) from spaceflight. In contrast, HLU caused a smaller reduction in 
bone volume (-10%) and stiffness (-15%) compared to whole bone volume (-17%) and stiffness 
(-22%).  
 Trabecular bone experienced greater relative reductions in bone volume and strength for 
HLU and spaceflight compared to the cortical compartments. Contrary to cortical and whole 
bone volume and stiffness, the trabecular bone compartment experienced greater reduction from 
HLU (-58%, -56%) compared to spaceflight (-32%, -45%). These results indicate that there are 
differences between the models that affects cortical and trabecular bone differently. The 
spaceflight model causes greater reductions in cortical bone stiffness, but smaller reductions in 
trabecular bone stiffness compared to HLU. Possible reasons for this difference may be the fluid 
shift in the HLU model that might affect trabecular bone more than cortical bone. Another 
explanation might be the difference in forces on the proximal tibia in the HLU model compared 
to spaceflight. The tibia bone hangs from the femur in the HLU model, and gravity is still present 
so there is a tensile load on the tibia cortical bone that might cause less bone resportion to occur 
compared to the spaceflight mice in a complete microgravity environment. 
The differences that occurred in bone volume and stiffness between spaceflight and HLU 
can be deduced from the structural efficiency results in which spaceflight reduced structural 
efficiency more (-22%) than HLU (-5%). Spaceflight caused a greater reduction in stiffness 
compared to bone volume for whole bone, as well as cortical and trabecular bone compartments. 
Alternatively, HLU caused a greater reduction in stiffness compared to bone volume for whole 
bone and cortical bone compartments, but not for trabecular bone compartment. The greater 
increase in stiffness (-56%) compared to bone volume (-58%) for trabecular bone due to HLU, 
and the smaller reductions that occurred in cortical bone compartments in both bone volume (-
10%) and stiffness (-15%) compared to spaceflight which had greater differences in reduction 
between bone volume (-14%) and stiffness (-32%) caused the large differences in structural 
efficiency between HLU and spaceflight. The greater decrease in structural efficiency in 
spaceflight might be caused by partial loading present in the HLU model. 
Furthermore, structural efficiency results showed an increase in trabecular structural 
efficiency from HLU, because stiffness decreased less than bone volume. Bone remodeling 
occurs throughout life to maintain efficiency in the skeletal system; however, the balance 
between osteoclast activity and osteoblast activity is often disrupted, causing osteoporosis later 
in life. In these cases, it might be useful to know the efficiency of the bone structure itself: Is 
more bone volume lost compared to stiffness or is the stiffness decreasing at a higher rate than 
bone volume? These answers could help assess bone health and fracture risk. For example, in the 
trabecular compartment, HLU was able to maintain stiffness more than volume (8% increase in 
structural efficiency), indicating that bone was lost in areas of decreased load concentration. On 
the other hand, spaceflight caused large decreases in structural efficiency, indicating that areas of 
high load concentration lost more bone than in the HLU model. 
 Scl-Ab mitigated the loss in BV and stiffness incurred by unloading in both models. Scl-
Ab increased BV more from HLU (48%) compared to spaceflight (39%), but less effectively 
since structural efficiency increased less from HLU (8%) compared to spaceflight (13%). 
However, it is important to note that the ground controls in the spaceflight experiment increased 
more in bone volume (42%, 60%) and stiffness from Scl-Ab compared to HLU (37%, 48%). 
These differences are most likely due to differences in the cage set-ups (AEM and HLU cage). 
With these differences in consideration, it seems that Scl-Ab was more effective in HLU 
compared to spaceflight for bone volume. Partial loading might have allowed Scl-Ab to produce 
greater effects. 
 Another difference between the models that could have affected the results is differences 
in mobility. The spaceflight mice could use their hind limbs, and were required to climb to reach 
food, but the HLU mice lost all mobility in limbs when suspended by the tail. Furthermore, the 
stressful microgravity environment and radiation effects could have altered the bone structure, 
enhancing the effects seen from unloading. 
Conclusions 
Exposure to 13-days of unloading during spaceflight and HLU resulted in a significant 
decrease in bone strength in the proximal tibia. Although the HLU model produced similar 
results to Spaceflight for bone volume, it did not accurately approximate stiffness or structural 
efficiency in the proximal tibia. Separating the meshes showed spaceflight to cause a greater 
reduction in cortical bone volume and stiffness than HLU, but a smaller decrease in trabecular 
bone volume and stiffness compared to HLU. Scl-Ab caused greater increases in stiffness 
compared to bone volume, thereby increasing structural efficiency. Furthermore, Scl-Ab 
increased stiffness more in HLU compared to spaceflight; however Scl-Ab increased structural 
efficiency more in spaceflight compared to HLU. Structural efficiency could be a new indicator 
of bone health, revealing how much the change in bone volume affects stiffness. Future studies 
could investigate biomarkers for bone remodeling.  
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Appendix 
 
 
 
Figure 7: The correlation coefficient shown above (R
2
=0.9239) demonstrates the relationship 
between failure load estimate and stiffness. 
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